Literature DB >> 18581473

Successful treatment of the Meige syndrome with oral zolpidem monotherapy.

Jae Young An, Joong-Seok Kim, Yeong-In Kim, Kwang Soo Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18581473     DOI： 10.1002/mds.22179

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  11 in total

Review 1.  Meige syndrome: what's in a name?

Authors:  Mark S LeDoux
Journal:  Parkinsonism Relat Disord       Date:  2009-05-19       Impact factor: 4.891

Review 2.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

Review 3.  Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation.

Authors:  Ian O Bledsoe; Aaron C Viser; Marta San Luciano
Journal:  Neurotherapeutics       Date:  2020-10-23       Impact factor: 7.620

4.  Efficacy of zolpidem for dystonia: a study among different subtypes.

Authors:  Yoshimichi Miyazaki; Wataru Sako; Kotaro Asanuma; Yuishin Izumi; Tetsuro Miki; Ryuji Kaji
Journal:  Front Neurol       Date:  2012-04-17       Impact factor: 4.003

5.  A case with improvement of blepharospasm by zolpidem.

Authors:  Munkyung Sunwoo; Junghee Cho; Jun Hong Lee; Gyu Sik Kim; Jong Hun Kim; Sun-Ah Choi
Journal:  J Mov Disord       Date:  2011-04-30

Review 6.  Medical treatment of dystonia.

Authors:  Pichet Termsarasab; Thananan Thammongkolchai; Steven J Frucht
Journal:  J Clin Mov Disord       Date:  2016-12-19

7.  Dystonic Dysarthria in Wilson Disease: Efficacy of Zolpidem.

Authors:  Aurélia Poujois; Michaela Pernon; Jean-Marc Trocello; France Woimant
Journal:  Front Neurol       Date:  2017-10-31       Impact factor: 4.003

Review 8.  Blepharospasm, Oromandibular Dystonia, and Meige Syndrome: Clinical and Genetic Update.

Authors:  Hongying Ma; Jian Qu; Liangjun Ye; Yi Shu; Qiang Qu
Journal:  Front Neurol       Date:  2021-03-29       Impact factor: 4.003

9.  Efficacy and Safety of Zolpidem for Focal Dystonia After Neurosurgical Treatments: A Retrospective Cohort Study.

Authors:  Shiro Horisawa; Kotaro Kohara; Hiroki Ebise; Masahiko Nishitani; Takakazu Kawamata; Takaomi Taira
Journal:  Front Neurol       Date:  2022-05-03       Impact factor: 4.003

Review 10.  Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease.

Authors:  Antonio Daniele; Francesco Panza; Antonio Greco; Giancarlo Logroscino; Davide Seripa
Journal:  Parkinsons Dis       Date:  2016-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.